Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Clinical Drug Investigation|April 15, 2008
Stereoselective disposition of proton pump inhibitorsTommy Andersson, Lars WeidolfChemical Research in Toxicology|June 25, 2013
Metabolism of xenobiotic carboxylic acids: focus on coenzyme A conjugation, reactivity, and interference with lipid metabolismMalin Darnell, Lars WeidolfBioanalysis|March 14, 2012
Conference Report: High-resolution MS in drug discovery and development: current applications and future perspectivesDaniel J Weston, Lars WeidolfRapid Communications in Mass Spectrometry : RCM|June 19, 2007
Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesisTove Johansson, Lars Weidolf, Ulrik JurvaDrug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2014
Systemic exposure to the metabolites of lesogaberan in humans and animals: a case study of metabolites in safety testingAnn Aurell Holmberg, Anja Ekdahl, Lars WeidolfRapid Communications in Mass Spectrometry : RCM|April 15, 2010
P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometryTove Johansson Mali'n, Lars Weidolf, Neal Castagnoli, et al.Chemical Research in Toxicology|March 26, 2008
Electrochemical generation of electrophilic drug metabolites: characterization of amodiaquine quinoneimine and cysteinyl conjugates by MS, IR, and NMRUlrik Jurva, Anders Holmén, Gunnar Grönberg, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 10, 2023
In Vivo Metabolite Profiles of an <i>N</i>-Acetylgalactosamine-Conjugated Antisense Oligonucleotide AZD8233 Using Liquid Chromatography High-Resolution Mass Spectrometry: A Cross-Species Comparison in Animals and HumansXue-Qing Li, Marie Elebring, Anders Dahlén, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2004
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activitiesXue-Qing Li, Tommy B Andersson, Marie Ahlström, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: structure elucidation using electrochemistry, mass spectrometry, and NMRTove Johansson, Ulrik Jurva, Gunnar Grönberg, et al.Pageof 4